Although the attention for neurodiversity in human resource management (HRM) is growing, neurodivergent individuals are still primarily supported from a deficit-oriented paradigm, which points towards individuals' deviation from neurotypical norms. Following the HRM process model, our study explored to what extent a strengths-based HRM approach to the identification, use, and development of strengths of neurodivergent groups is intended, implemented, and perceived in organizations. Thirty participants were interviewed, including HRM professionals (n=15), supervisors of neurodivergent employees (n=4), and neurodivergent employees (n=11). Our findings show that there is significant potential in embracing the strengths-based approach to promote neurodiversity-inclusion, for instance with the use of job crafting practices or (awareness) training to promote strengths use. Still, the acknowledgement of neurodivergent individuals' strengths in the workplace depends on the integration of the strengths-based approach into a supportive framework of HR practices related to strengths identification, use, and development. Here, particular attention should be dedicated to strengths development for neurodivergent employees (e.g., optimally balancing strengths use). By adopting the strengths-based HRM approach to neurodiversity as a means of challenging the ableist norms of organizations, we add to the HRM literature by contributing to the discussion on how both research and organizations can optimally support an increasingly diverse workforce by focusing on individual strengths
The World Health Organization has pinpointed antimicrobial resistance (AMR) of increasing global concern, causing increased healthcare costs and threatening human health. Although AMR is a naturally occurring process, it is accelerated by misuse/overuse of antibiotics. Additionally, the development and production of antibiotics is becoming increasingly challenging and costly. These challenges underline the high demand for alternative microbial inhibitors (e.g. antibiotics) and their development. The chemical compound Allicin has been studied for its potential health benefits, including antimicrobial properties[1,2] and potential cardiovascular benefits[3]. It has been suggested that the antimicrobial effect of Allicin could be achieved indirectly by the imprint it leaves in surrounding water molecules, i.e. its hydration shell. Such imprints are known as time-crystals and possess unique properties. Since often biochemical reactions occur via water molecules and their hydrogen bonds, it is possible that a time-crystal imprint of a substance in water might have a similar effect as the substance itself, e.g. antimicrobial inhibition. A consortium of universities, knowledge institutes and companies was formed to test this hypothesis based on the antibacterial properties of Allicin, resulting in the project HyTimeCIA. The experiments involve attaching allicin onto a polymer surface (i.e. hybridization), thereby providing antibacterial properties. This surface is then exposed to bacteria to test the antimicrobial properties of the allicin/polymer surface. If proven feasible, HyTimeCIA could provide a novel alternative microbial inhibitor fixated to a surface, allowing for localized application of antibacterial effects and potentially reducing the requirement of antibiotics. This not only mitigates AMR, but also facilitates production of microbial inhibitors that are particularly difficult or expensive. From the partners perspective, HyTimeCIA provides opportunities for chemical-free alternative antimicrobial (water)treatment technology and gained knowledge on alternative microbial inhibitors, both aspects which are highly in demand due to AMR and antibiotic production challenges.